Advertisement

The expression of Aquaporin-1 and Aquaporin-3 in extrahepatic cholangiocarcinoma and their clinicopathological significance

Published:November 17, 2021DOI:https://doi.org/10.1016/j.amjms.2021.11.004

      Abstract

      Background

      The aim of the study was to evaluate the expression and clinicopathological significance of Aquaporin-1 (AQP1) and Aquaporin-3 (AQP3) in extrahepatic cholangiocarcinoma (EHCC).

      Methods

      Immunostaining of AQP1 and AQP3 was performed by EnVision immunohistochemistry in benign and malignant biliary tract tissues.

      Results

      The expression of AQP1 and AQP3 protein were significantly higher in EHCC tumor tissues (P < 0.05 or P < 0.01). Adenoma and paracancerous tissues with positive AQP1 and/or AQP3 protein expression exhibited atypical hyperplasia. AQP1 expression was positive correlated with AQP3 expression in EHCC (P < 0.01). TNM I + II stage and radical surgery, the positive expression of AQP1 and AQP3 In patients with well-differentiation, no invasion, no lymph metastasis, is lower (P < 0.05 or P < 0.01). Average overall survival time of those with positive expression of AQP1 and AQP3 was significant shorter (P < 0.01). Both AQP1 and AQP3 positive expressions were proved to be an independent prognostic factors in EHCC by cox multivariate analysis. The AUC calculated for AQP1 was 0.769 (95% confidence interval [CI]: 0.618–0.920), and that for AQP3 was 0.758 (95%CI: 0.605–0.911, while that for AQP1 and AQP3 was 0.825 (95%CI: 0.658–0.991).

      Conclusions

      Positive expression of AQP1 and AQP3 is closely related to the pathogenesis, severe clinicopathological characteristics, aggressive biological behaviors, and dismal prognoses in EHCC.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Esnaola NF
        • Meyer JE
        • Karachristos A
        • et al.
        Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
        Cancer. 2016; 122: 1349-1369
        • Razumilava N
        • Gores GJ
        Cholangiocarcinoma.
        Lancet. 2014; 383: 2168-2179
        • Rizzo A
        • Ricci AD
        • Brandi G
        Recent advances of immunotherapy for biliary tract cancer.
        Expert Rev Gastroenterol Hepatol. 2021; : 1-10
        • Rizvi S
        • Khan SA
        • Hallemeier CL
        • et al.
        Cholangiocarcinoma-evolving concepts and therapeutic strategies.
        Nat Rev Clin Oncol. 2018; 15: 95-111
        • Zelenina M
        • Zelenin S
        • Aperia A
        Water channels (aquaporins) and their role for postnatal adaptation.
        Pediatr Res. 2005; 57: 47R-53R
        • Borgnia M
        • Nielsen S
        • Engel A
        • et al.
        Cellular and molecular biology of the aquaporin water channels.
        Annu Rev Biochem. 1999; 68: 425-458
        • Verkman AS
        • Mitra AK
        Structure and function of aquaporin water channels.
        Am J Physiol Renal Physiol. 2000; 278: F13-F28
        • Ishibashi K
        • Kuwahara M
        • Sasaki S
        Molecular biology of aquaporins.
        Rev Physiol Biochem Pharmacol. 2000; 141: 1-32
        • Verkman AS.
        More than just water channels: unexpected cellular roles of aquaporins.
        J Cell Sci. 2005; 118: 3225-3232
        • De Ieso ML
        • Yool AJ
        Mechanisms of aquaporin-facilitated cancer invasion and metastasis.
        Front Chem. 2018; 6: 135
        • Aikman B
        • de Almeida A
        • Meier-Menches SM
        • et al.
        Aquaporins in cancer development: opportunities for bioinorganic chemistry to contribute novel chemical probes and therapeutic agents.
        Metallomics. 2018; 10: 696-712
        • Delporte C
        • Bryla A
        • Perret J
        Aquaporins in salivary glands: from basic research to clinical applications.
        Int J Mol Sci. 2016; 17
        • Soveral G
        • Casini A
        Aquaporin modulators: a patent review (2010-2015).
        Expert Opin Ther Pat. 2017; 27: 49-62
        • Tradtrantip L
        • Jin BJ
        • Yao X
        • et al.
        Aquaporin-targeted therapeutics: state-of-the-field.
        Adv Exp Med Biol. 2017; 969: 239-250
        • Abir-Awan M
        • Kitchen P
        • Salman MM
        • et al.
        Inhibitors of mammalian aquaporin water channels.
        Int J Mol Sci. 2019; 20
        • Alevizos I
        • Zheng C
        • Cotrim AP
        • et al.
        Late responses to adenoviral-mediated transfer of the Aquaporin-1 gene for radiation-induced salivary Hypofunction.
        Gene Ther. 2017; 24: 176-186
        • Nagaraju GP
        • Basha R
        • Rajitha B
        • et al.
        Aquaporins: their role in gastrointestinal malignancies.
        Cancer Lett. 2016; 373: 12-18
        • Seay M
        • Rucker JC
        Neuromyelitis optica: review and utility of testing Aquaporin-4 Antibody in typical optic neuritis.
        Asia Pac J Ophthalmol (Phila). 2018; 7: 229-234
        • Jakowiecki J
        • Sztyler A
        • Filipek S
        • et al.
        Aquaporin-graphene interface: relevance to point-of-care device for renal cell carcinoma and desalination.
        Interface Focus. 2018; 8: 20170066
        • Lan YL
        • Wang X
        • Lou JC
        • et al.
        The potential roles of aquaporin 4 in malignant gliomas.
        Oncotarget. 2017; 8: 32345-32355
        • Direito I
        • Madeira A
        • Brito MA
        • et al.
        Aquaporin-5: from structure to function and dysfunction in cancer.
        Cell Mol Life Sci. 2016; 73: 1623-1640
        • Direito I
        • Paulino J
        • Vigia E
        • et al.
        Differential expression of Aquaporin-3 and Aquaporin-5 in pancreatic ductal adenocarcinoma.
        J Surg Oncol. 2017; 115: 980-996
        • Dajani S
        • Saripalli A
        • Sharma-Walia N
        Water transport proteins-aquaporins (AQPs) in cancer biology.
        Oncotarget. 2018; 9: 36392-36405
        • Shi YH
        • Chen R
        • Talafu T
        • et al.
        Significance and expression of Aquaporin 1, 3, 8 in cervical carcinoma in xinjiang uygur women of China.
        Asian Pac J Cancer Prev. 2012; 13: 1971-1975
        • Saadoun S
        • Papadopoulos MC
        • Davies DC
        • et al.
        Increased Aquaporin 1 water channel expression in human brain tumours.
        Br J Cancer. 2002; 87: 621-623
        • Oshio K
        • Binder DK
        • Liang Y
        • et al.
        Expression of the Aquaporin-1 water channel in human glial tumors.
        Neurosurgery. 2005; 56 (discussion 375-81): 375-381
        • Kang BW
        • Kim JG
        • Lee SJ
        • et al.
        Expression of Aquaporin-1, Aquaporin-3, and Aquaporin-5 correlates with nodal metastasis in colon cancer.
        Oncology. 2015; 88: 369-376
        • Qin F
        • Zhang H
        • Shao Y
        • et al.
        Expression of Aquaporin1, a water channel protein, in cytoplasm is negatively correlated with prognosis of breast cancer patients.
        Oncotarget. 2016; 7: 8143-8154
        • Wang J
        • Feng L
        • Zhu Z
        • et al.
        Aquaporins as diagnostic and therapeutic targets in cancer: how far we are?.
        J Transl Med. 2015; 13: 96
        • Esteva-Font C
        • Jin BJ
        • Verkman AS
        Aquaporin-1 gene deletion reduces breast tumor growth and lung metastasis in tumor-producing MMTV-PyVT Mice.
        Faseb J. 2014; 28: 1446-1453
        • Yoshida T
        • Hojo S
        • Sekine S
        • et al.
        Expression of Aquaporin-1 is a poor prognostic factor for stage II and III colon cancer.
        Mol Clin Oncol. 2013; 1: 953-958
        • Burghardt B
        • Elkaer ML
        • Kwon TH
        • et al.
        Distribution of Aquaporin water channels AQP1 and AQP5 in the ductal system of the human pancreas.
        Gut. 2003; 52: 1008-1016
        • Yang B
        • Verkman AS
        Water and glycerol permeabilities of Aquaporins 1-5 and MIP determined quantitatively by expression of epitope-tagged constructs in Xenopus oocytes.
        J Biol Chem. 1997; 272: 16140-16146
        • Kang S
        • Chae YS
        • Lee SJ
        • et al.
        Aquaporin 3 expression predicts survival in patients with HER2-positive early breast cancer.
        Anticancer Res. 2015; 35: 2775-2782
        • Shen L
        • Zhu Z
        • Huang Y
        • et al.
        Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance.
        Biomed Pharmacother. 2010; 64: 313-318
        • Li A
        • Lu D
        • Zhang Y
        • et al.
        Critical role of Aquaporin-3 in epidermal growth factor-induced migration of colorectal carcinoma cells and its clinical significance.
        Oncol Rep. 2013; 29: 535-540
        • Hwang I
        • Jung SI
        • Hwang EC
        • et al.
        Expression and localization of aquaporins in benign prostate hyperplasia and prostate cancer.
        Chonnam Med J. 2012; 48: 174-178
        • Seleit I
        • Bakry OA
        • Ragheb E
        • et al.
        Evaluation of Aquaporin-3 role in nonmelanoma skin cancer: an immunohistochemical study.
        Ultrastruct Pathol. 2015; 39: 306-317
        • Liu S
        • Zhang S
        • Jiang H
        • et al.
        Co-expression of AQP3 and AQP5 in esophageal squamous cell carcinoma correlates with aggressive tumor progression and poor prognosis.
        Med Oncol. 2013; 30: 636
        • Matsuo K
        • Kawano K
        Immunohistochemical distribution and morphometric analysis of Aquaporin-3 in oral squamous cell carcinoma.
        Int J Oral Maxillofac Surg. 2014; 43: 13-21
        • Liu YL
        • Matsuzaki T
        • Nakazawa T
        • et al.
        Expression of Aquaporin 3 (AQP3) in normal and neoplastic lung tissues.
        Hum Pathol. 2007; 38: 171-178
        • Xu S
        • Huang S
        • Li D
        • et al.
        Negative expression of DSG1 and DSG2, as prognostic biomarkers, impacts on the overall survival in patients with extrahepatic cholangiocarcinoma.
        Anal Cell Pathol (Amst). 2020; 2020: 9831646
        • Zou W
        • Yang Z
        • Li D
        • et al.
        AQP1 and AQP3 Expression are Associated with Severe Symptoms and Poor-Prognosis of the Pancreatic Ductal Adenocarcinoma.
        Appl Immunohistochem Mol Morphol. 2019; 27: 40-47
      1. Moosavi MS, Elham Y. Aquaporins 1, 3 and 5 in different tumors, their expression, prognosis value and role as new therapeutic targets. Pathol Oncol Res. 2019.

        • Nagaraju GP
        • Basha R
        • Rajitha B
        • et al.
        Aquaporins: their role in gastrointestinal malignancies.
        Cancer Lett. 2016; 373: 12-18
        • Shi Z
        • Zhang T
        • Luo L
        • et al.
        Aquaporins in human breast cancer: identification and involvement in carcinogenesis of breast cancer.
        J Surg Oncol. 2012; 106: 267-272
        • Rizzo A
        • Tavolari S
        • Ricci AD
        • et al.
        Molecular features and targeted therapies in extrahepatic cholangiocarcinoma: promises and failures.
        Cancers (Basel). 2020; 12: 3256